Hi @TRr,
All good and well - it's been an exciting past few weeks and hopefully more to come. Like many, I'm in the "No" camp for the $3 T/O so haven't sold a single share.
I did have an interesting catch up with my former Boss who tipped me to look into LTR back in 2019 for them. Similar to some already reported here, he received a call from Gina's broker offering to buy their shares at $3 and was contemplating about it.
The GM at my current employer also checked in with me yesterday wondering what she (Gina) was up to - he used to work in a senior role for one of the Top 20 holder (a local WA businessman); his view is that, if Gina has her own interest in mind by acquiring a substantial stake, he see little reason why it would be adverse for the other shareholders unless her plan is to to take LTR for herself.
Anyway, I had worked out some numbers when LTR provided us the Project (capex) update however it's just not quite there yet as @ChocolateTeapot suggested; I will put them up once the funding mix is sorted.
For the time being; and with reference to my previous post - excluding the DSO; I previously estimated a funding shortfall of $400m as opposed to LTR's project update of $450m; at minimum. They did indicate they may seek more than that - I'm now expecting at least another $100m taking it to $550m.
And in relation to today's announcement, it shouldn't be a surprise. As some of you may know - I'm in the asset investment industry working for a listed company managing listed/unlisted funds - even deals/finance under $50m can have delays up to weeks for whatever reasons. And capital raise does take time unless it's already a done deal among a handful of ultra high net worth investors before the info is made known.
For now, I'm glad Albemarle did not proceed with the $3 T/O saving us from getting a huge tax bill... for now.
As some already noted, if Albemarle and Gina is willing to pay $3/share (premium or not) for LTR. Last I checked; they're in a business of making money - they clearly believe LTR is worth more.
- Forums
- ASX - By Stock
- LTR
- ASX Today
ASX Today, page-33779
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.073B |
Open | High | Low | Value | Volume |
85.5¢ | 89.0¢ | 84.5¢ | $11.18M | 12.91M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11235 | 85.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.0¢ | 19200 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8235 | 0.850 |
3 | 90000 | 0.845 |
11 | 152249 | 0.840 |
4 | 10394 | 0.835 |
10 | 69011 | 0.830 |
Price($) | Vol. | No. |
---|---|---|
0.860 | 19200 | 2 |
0.870 | 38200 | 2 |
0.875 | 98119 | 3 |
0.880 | 42805 | 5 |
0.885 | 77100 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online